Ocular Disease: Mechanisms and Management

<p>SECTION 1 Cornea </p> <p>1. Loss of corneal transparency </p> <p>Russell L McCally </p> <p>2. Abnormalities of corneal wound healing </p> <p>Audrey M Bernstein </p> <p>3. Wound healing after laser in situ keratomileusis and photorefractive keratectomy </p> <p>Fabricio Witzel de Medeiros and Steven E Wilson </p> <p>4. Genetics and mechanisms of hereditary corneal dystrophies </p> <p>John D Gottsch </p> <p>5. Fuchs’ endothelial corneal dystrophy </p> <p>Vinay Gutti, David S Bardenstein, Sudha Iyengar, and Jonathan H Lass </p> <p>6. Keratoconus </p> <p>M Cristina Kenney and Ronald N Gaster </p> <p>7. Infectious keratitis </p> <p>Michael S Gilmore, Susan R Heimer, and Ai Yamada </p> <p>8. Corneal graft rejection</p> <p>Daniel R Saban, Mohammad H Dastjerdi, and Reza Dana</p> <p>9. Corneal edema</p> <p>Daniel G Dawson and Henry F Edelhauser </p> <p>10. Corneal angiogenesis and lymphangiogenesis </p> <p>Chih-Wei Wu, David Ellenberg, and Jin-Hong Chang </p> <p>11. Ocular surface restoration </p> <p>Julie T Daniels, Genevieve A Secker, and Alex J Shortt </p> <p>12. Herpetic keratitis</p> <p>Pranita P Sarangi and Barry T Rouse </p> <p>13. Ocular allergy</p> <p>Neal P Barney, Ellen B Cook, James L Stahl, and Frank M Graziano </p> <p>SECTION 2 Dry eye </p> <p>14. The lacrimal gland and dry-eye disease</p> <p>Darlene A Dartt </p> <p>15. Immune mechanisms of dry-eye disease </p> <p>Austin K Mircheff and Joel E Schechter </p> <p>16. Disruption of tear film and blink dynamics</p> <p>Jianhua Wang and Anuj Chauhan </p> <p>17. Abnormalities of eyelid and tear film lipid </p> <p>Gary N Foulks and Douglas Borchman </p> <p>18 Dry eye: abnormalities of tear film mucins </p> <p>Ann-Christin Albertsmeyer and Ilene K Gipson </p> <p>SECTION 3 Glaucoma </p> <p>19. Steroid-induced glaucoma </p> <p>Abbot F Clark, Xinyu Zhang, and Thomas Yorio </p> <p>20. Biomechanical changes of the optic disc </p> <p>Ian A Sigal, Michael D Roberts, Michael JA Girard, Claude F Burgoyne, and J Crawford Downs </p> <p>21. Pigmentary dispersion syndrome and glaucoma</p> <p>Michael G Anderson </p> <p>22. Abnormal trabecular meshwork outflow </p> <p>Paul A Knepper and Beatrice YJT Yue </p> <p>23. Pressure-induced optic nerve damage</p> <p>James C Tsai </p> <p>24. Exfoliation (pseudoexfoliation) syndrome </p> <p>Robert Ritch and Ursula Schlötzer-Schrehardt </p> <p>25. Angle closure glaucoma </p> <p>Shamira Perera, Nishani Amerasinghe, and Tin Aung</p> <p>26. Central nervous system changes in glaucoma</p> <p>Yeni N Yücel and Neeru Gupta </p> <p>27. Retinal ganglion cell death in glaucoma </p> <p>Heather R Pelzel and Robert W Nickells </p> <p>28. Wound-healing responses to glaucoma surgery</p> <p>Stelios Georgoulas, Annegret Dahlmann-Noor, Stephen Brocchini, and Peng Tee Khaw </p> <p>29. Blood flowchanges in glaucoma </p> <p>Leopold Schmetterer and Mark Lesk </p> <p>SECTION 4 Lens </p> <p>30. Biochemical mechanisms of age-related cataract</p> <p>David C Beebe, Ying-Bo Shui, and Nancy M Holekamp </p> <p>31. Posterior capsule opacification </p> <p>Judith West-Mays and Heather Sheardown</p> <p>32. Diabetes-associated cataracts </p> <p>Peter F Kador </p> <p>33. Steroid-induced cataract</p> <p>Abbas Samadi </p> <p>34. Presbyopia</p> <p>Jane F Koretz </p> <p>35. Restoration of accommodation</p> <p>Stephen D McLeod and Michelle Trager Cabrera</p> <p>36. Intraoperative floppy iris syndrome</p> <p>Amy Lin and Roger F Steinert </p> <p>SECTION 5 Neuro-ophthalmology </p> <p>37. Optic neuritis </p> <p>John R Guy and Xiaoping Qi </p> <p>38. Abnormal ocular motor control </p> <p>James A Sharpe and Arun Sundaram </p> <p>39. Idiopathic intracranial hypertension (idiopathic pseudotumor cerebri) </p> <p>Deborah M Grzybowski and Martin Lubow </p> <p>40. Giant cell arteritis</p> <p>Lynn K Gordon </p> <p>41. Ischemic optic neuropathy </p> <p>Helen Danesh-Meyer </p> <p>42. Optic nerve axonal injury </p> <p>Daniela Toffoli and Leonard A Levin </p> <p>43. Leber’s hereditary optic neuropathy </p> <p>Alfredo Sadun and Alice Kim </p> <p>44. Optic atrophy </p> <p>Nathan T Tagg and Randy H Kardon </p> <p>45. Nystagmus</p> <p>Frank Proudlock and Irene Gottlob </p> <p>46. Toxic optic nerve neuropathies</p> <p>FT "Fritz" Fraunfelder and FW "Rick" Fraunfelder </p> <p>SECTION 6 Oncology </p> <p>47. Uveal melanoma</p> <p>Zélia MS Corrêa and J William Harbour </p> <p>48. Genetics of hereditary retinoblastoma </p> <p>Alejandra G de Alba Campomanes and Joan M O’Brien </p> <p>49. Molecular basis of low-penetrance retinoblastoma </p> <p>Katie Matatall and J William Harbour </p> <p>50. Vasculogenic mimicry </p> <p>Robert Folberg and Andrew J Maniotis </p> <p>51. Treatment of choroidal melanoma</p> <p>Aimee V Chappelow and Andrew P Schachat </p> <p>52. Sebaceous cell carcinoma </p> <p>Alon Kahana, Jonathan T Pribila, Christine C Nelson, and Victor M Elner </p> <p>53. Neurofibromatosis </p> <p>Robert Listernick and David H Gutmann </p> <p>SECTION 7 Other </p> <p>54 Phthisis bulbi </p> <p>Ingo Schmack, Hans E Völcker, and Hans E Grossniklaus </p> <p>55. Myopia</p> <p>Terri L Young </p> <p>56. Pathogenesis of Graves’ ophthalmopathy</p> <p>A Reagan Schiefer and Rebecca S Bahn </p> <p>SECTION 8 Pediatrics </p> <p>57. Duane syndrome </p> <p>Joseph L Demer </p> <p>58. Amblyopia</p> <p>Robert F Hess and Nigel Daw </p> <p>59 Strabismus </p> <p>Christopher S von Bartheld, Scott A Croes, and L Alan Johnson </p> <p>60. Albinism</p> <p>Gerald F Cox and Anne B Fulton </p> <p>61. Aniridia</p> <p>Elias I Traboulsi </p> <p>SECTION 9 Retina </p> <p>62. Color vision defects </p> <p>Maureen Neitz and Jay Neitz </p> <p>63. Acute retinal vascular occlusive disorders </p> <p>Sohan Singh Hayreh </p> <p>64. Retinal photic injury: laboratory and clinical findings </p> <p>Daniel Organisciak and Marco Zarbin </p> <p>65. Vascular damage in diabetic retinopathy </p> <p>Timothy S Kern and Suber Huang </p> <p>66. Neovascularization in diabetic retinopathy </p> <p>Corey B Westerfeld and Joan W Miller </p> <p>67. Diabetic macular edema </p> <p>Pascale Massin, Michel Paques, and Jean-Antoine Pournaras</p> <p>68. Dry age-related macular degeneration and age-related macular degeneration pathogenesis</p> <p>Marco Zarbin and Janet S Sunness </p> <p>69. Neovascular age-related macular degenerationDavid E Lederer, Scott W Cousins, and Karl G Csaky</p> <p>70. Inhibition of </p> <p>Anthony P Adamis and Adrienne Berman </p> <p>71. Retinal detachment </p> <p>Steven K Fisher and Geoffrey P Lewis </p> <p>72. Retinopathy of prematurity </p> <p>Mary Elizabeth Hartnett and Cynthia A Toth </p> <p>73. Retinal energy metabolism </p> <p>Robert A Linsenmeier </p> <p>74. Retinitis pigmentosa and related disorders</p> <p>Eric A Pierce </p> <p>75 Visual prostheses and other assistive devices </p> <p>Muhammad Ali Memon and Joseph F Rizzo III </p> <p>76. Paraneoplastic retinal degeneration </p> <p>Grazyna Adamus </p> <p>77. Cellular repopulation of the retina </p> <p>Budd AL Tucker, Michael J Young, and Henry J Klassen </p> <p>78. Proliferative vitreoretinopathy </p> <p>Clyde Guidry </p> <p>SECTION 10 Uveitis </p> <p>79. Immunologic mechanisms of uveitis </p> <p>Steven Yeh, Zhuqing Li, and Robert B Nussenblatt </p> <p>80. Herpesvirus retinitis </p> <p>Sally S Atherton and Mei Zheng </p> <p>81. Sympathetic ophthalmia </p> <p>Mirunalini Kumaradas and Narsing A Rao </p> <p>82. Scleritis </p> <p>Srilakshmi M Sharma and James T Rosenbaum </p> <p>83 Infectious uveitis </p> <p>Pooja Bhat, Allen Tony Jackson, and C Stephen Foster </p> <p>84. Ocular sarcoidosis </p> <p>Russell N Van Gelder and Suzanne M Dintzis </p> <p>Index</p>